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a  b  s  t  r  a  c  t
Endoscopic  capsules  and  endoscopy  were  used  to  assess  the  speed  of  kill  and  the  clearance
of  hookworms  in  dogs  experimentally  infected  with  Ancylostoma  caninum.  A total  of  four
adult dogs  were  inoculated  in  two  separate  cohorts  comprised  of  two  4-year-old  females
and two 7-year-old  males.  Dogs  were  treated  topically  with  Advantage  Multi® for Dogs
13 days  (Cohort  1)  or 16 days  (Cohort  2)  after  infection.  Endoscopic  imaging  of  the  small
intestine  was  carried out both  pre-  and  post-treatment.  Examination  of  the  ﬁrst  cohort
revealed  that  the worms  had  been  cleared  and  the  hookworm-induced  lacerations  were
markedly  diminished  within  48  h  of  treatment.  In the second  cohort,  endoscopic  capsules
were  given  the  day  of, the  day  after, and  two  days  after  treatment;  within  24 h of productIn vivo
Lesions
Therapy
administration,  the  worms  had  been  removed  with  a concurrent  reduction  in observed
lesions.  Topical  application  of  Advantage  Multi® for Dogs  rapidly  removed  worms  from  the
small intestine  of  the  dogs  in  this  study  as  early  as 24 h  post-treatment,  with  a marked
reduction  in the  number  of  mucosal  lesions  seen.
©  2014  The  Authors.  Published  by  Elsevier  B.V.  This  is an  open  access  article  under  the  CC
Y-NC-NB
1. Introduction
In the Freedom of Information summary of the New
Animal Drug Application (NADA) made to the Food and
Drug Administration (FDA) for the approval of Advantage
Multi® for Dogs, the time from treatment to necropsy
in the efﬁcacy trials against intestinal helminths (Ancy-
lostoma caninum, Uncinaria stenocephala, Toxocara canis,
Toxascaris leonina, and Trichuris vulpis)  is 10 days (NADA
141-251). FDA Guidance Document 111 for the effective-
ness of anthelmintics in canines (VICH GL19) states that
“with the majority of parasites seven days is a sufﬁcient
time period from the termination of treatment until the
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animals are necropsied,” but exceptions are presented for
other helminths, including the gastrointestinal dwelling
species of Physaloptera, Spirocerca,  Echinococcus, Taenia,
Dipylidium, and Mesocestoides where the time is extended
to 10 days. For approval purposes, because Advantage
Multi® for Dogs is applied topically and takes 9 days to
reach maximum plasma concentrations (NADA 141-251),
10 days post-treatment was  a logical time point to assess
efﬁcacy based on postmortem worm counts.
The development of endoscopy, and particularly endo-
scopic camera capsules, has now provided a means to
examine intestinal helminths in vivo at different time
points after infection (Lee et al., 2011, 2013; Liotta et al.,
2012). This would also potentially allow for assessment of
the rate of worm clearance after treatment and, in the case
of hookworms, the resultant effects on the lesions caused
by feeding adult worms. Blood lost to feeding hookworms
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as been reported to occur in two peaks after infection:
ne during the very rapid growth of the maturing adult
orms (10–15 days after infection) and one at 20 days
fter infection when maximal egg output begins (Miller,
966). Advantage Multi® for Dogs is labeled for the treat-
ent of fourth-stage larvae and both immature and mature
dult worms, and thus, treatment was applied in this study
arlier than the routinely used time point of >21 days
ost-infection to minimize blood loss by the dogs. This
ork documented the effects of anthelmintic treatment on
opulations of young A. caninum and subsequent resolution
f hookworm-induced intestinal lesions.
. Materials and methods
.1. Animals
All work was performed under a protocol approved
y Cornell University’s Institutional Animal Care and Use
ommittee. The four Beagle dogs used in this study had
een acquired from an approved Class A dealer (Marshall
ioResources, North Rose, NY) and had resided in Cor-
ell’s research facility for a number of years as part of an
nrelated investigation into canine herpesvirus-associated
cular disease. The work was performed in two  cohorts
ith two 4-year-old females in Cohort 1 and two 7-year-
ld males in Cohort 2. At the beginning of the trial utilizing
ohort 1, all dogs were transferred from the room in which
hey had been housed to a different room within the same
acility. The female dogs were housed together, but due to
etween-dog aggressive tendencies, the male dogs were
oused individually. Although transferred at the same time,
ogs were monitored for the study such that there was a
 day (Cohort 1) or 7 day (Cohort 2) acclimation period to
he new room before the study began, i.e., the day on which
he dogs received their hookworm infections (Day 0). Dogs
eceived initial physical examinations between Days −5
nd −2; all were clinically healthy. The study ended on Day
2 (Cohort 1) or 25 (Cohort 2) and, this being a non-terminal
tudy, at study completion the dogs were transferred back
o the previous investigator.
.2. Infection and treatments administered
On Day 0 for each cohort, the dogs were orally inocu-
ated with 500 third-stage larvae of A. caninum that had
een grown in charcoal cultures (Bowman et al., 1991).
he source of the larvae was a fecal sample from a ran-
om source dog supplied by Cheri-Hill Kennel and Supply,
nc., Stanwood, MI.  The larvae were grown in culture for
 days prior to harvest and were stored in water at room
emperature in T-25 vented tissue culture ﬂasks until used.
liquot counts were made for preparing the doses to infect
he dogs in Cohorts 1 and 2, respectively. The dogs were
reated with Advantage Multi® for Dogs at the dose band
ecommended by the manufacturer for their weight. For
ohort 1, treatment (equivalent to 6.8 mg/kg moxidectin)
as administered on Day 13 of the trial, and for Cohort
, treatment (4.6–5.5 mg/kg moxidectin) was applied on
ay 16. Fecal samples from these dogs were examined byology 204 (2014) 402–406 403
sucrose centrifugal ﬂotation on Days 19 and 24 for Cohorts
1 and 2, respectively.
2.3. Endoscopic examination
Dogs were fasted overnight prior to each endoscopic
examination, then fed after completion of the proce-
dure. Capsule endoscopy was performed according to the
method previously described (Lee et al., 2011). Brieﬂy, dogs
were instrumented with external antennae along the ven-
tral body wall, ﬁtted with a jacket and pouch holding the
image recording device, and the endoscopic capsule was
then given by mouth. After image acquisition, instruments
were removed and the dog’s feces were checked for cap-
sule expulsion. Stored images were downloaded onto a
computer for review. For conventional endoscopy, dogs
were premedicated with a butorphanol–midazolam mix-
ture, induced with propofol, and maintained under general
anesthesia with isoﬂurane inhalant gas. Examination of the
duodenum was  carried out as per standard endoscopic pro-
tocols. Dogs were monitored until fully recovered from
anesthesia. In Cohort 1, the dogs were examined with
endoscopic capsules on Days 7, 9, 12, and 15, and with a
conventional endoscope on Days 11 and 16. The dogs in
Cohort 2 were examined by capsule endoscopy on Days 9,
12, and 15–18, and by conventional endoscopy on days 14
and 19.
3. Results
In the examination of the images collected from Cohort
1, hookworm-induced lacerations were observable as early
as Day 7 (Fig. 1A), the ﬁrst day that endoscopic capsules
were given to the dogs. Worms  were seen on Day 9 (Fig. 1B),
and this was  veriﬁed with endoscopy on Day 11 (Fig. 1C
and D; see also Video 1 online). Worms  were larger and
more numerous on Day 12, with mucosal hemorrhages still
being present as would be expected (Fig. 1E and F). Cohort
1 dogs were treated on Day 13, and the endoscopic cap-
sule images captured on Day 15 (2 days post-treatment,
DPT) showed the presence of healing scars only (Fig. 1G);
this was supported by the endoscopy views collected on
Day 16 (3 DPT) (Fig. 1H and I). Centrifugal ﬂotation of
feces collected on Day 19 was  negative for hookworm
eggs.
In the case of Cohort 2, worms and lesions were obvious
from the images collected from Day 9 (Fig. 2A) and Day 12
(Fig. 2B) through Day 14 (Fig. 2C and D; see Video 2). These
dogs were treated on Day 16, and images collected by cap-
sule endoscopy on this day showed that worms  and lesions
were abundant (Fig. 2E and F; see Video 3). However, by
Day 17 (1 DPT), worms were no longer present in the small
intestine and lesions were few in number (Fig. 2G). Again,
this was veriﬁed by endoscopy performed on Day 19 (3
DPT), which showed only a few small lesions remaining
as compared to the extensive lesions present before treat-
ment (Fig. 2H and I; see Video 4). Fecal examination on Day
24 revealed no hookworm eggs.
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Fig. 1. Immature adult Ancylostoma caninum and associated intestinal bleeding in dogs of Cohort 1, showing resolution after treatment with Advantage
Multi® for Dogs. (A) Small bowel mucosal hemorrhage, Day 7 post-infection. (B) Young A. caninum, Day 9. (C) Abandoned feeding site, Day 11. (D) Immature
adult  hookworm (bottom center), Day 11, camouﬂaged by the surrounding intestinal villi and a large amount of frank blood (see corresponding Video 1).
ched to
ormal-l
oscopy i(E)  Solitary hookworm nestled in blood, Day 12. (F) Three A. caninum atta
(2  days post-treatment), presumed to be healing lacerations. (H and I) N
capsule endoscopy images and panels C, D, H, and I are conventional end
4. Discussion
The discovery that the worms and associated hemor-
rhage in dogs of Cohort 1 had been cleared by the second
day post-treatment prompted a modiﬁcation of the sched-
ule of events for the next set of dogs. Thus, in Cohort 2,
two additional endoscopic capsules were given: one on
the day of treatment and another on the following day.
Images from Cohort 2 clearly demonstrated that as early
as 24 h after topical treatment with Advantage Multi®, A.
caninum worms were removed and lesions were reduced
in number. Another difference between the two  cohorts
was the delaying of treatment for Cohort 2 to Day 16;
this three-day postponement permitted the development
of extensive and severe lesions by Day 14 (Fig. 2C) that mucosa, Day 12. (G) Focal blanched areas on the intestinal wall, Day 15
ooking bowel, Day 16 (3 days post-treatment). Panels A, B, and E–G are
mages.
were not present in Cohort 1 (Fig. 1G–I). The speed with
which the worms were removed from the intestine after
treatment was  much more rapid than had been anticipated
when the study was designed. It is possible, however, that
a few worms may  have still been present in the colon 24 h
after treatment, because this segment of the intestinal tract
is not examined by the small bowel endoscopic capsule, and
colonoscopies were not performed.
Fecal examinations were not performed on these dogs
except for the purpose of verifying that they were egg-
negative before being returned to the care of their original
investigator. Because the worms  were young, eggs may  not
have been present in the feces of the dogs in Cohort 1 that
were treated on Day 13 post-infection, and the females
would not have yet reached their maximal egg production
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Fig. 2. Intestinal lacerations in Ancylostoma caninum-infected dogs of Cohort 2, with rapid healing after treatment with Advantage Multi® for Dogs. (A)
Young  hookworm on Day 9 post-infection, curled up in pooling blood. (B) Immature adult A. caninum, Day 12. (C) Numerous hookworm-induced lacerations,
Day  14 (see Video 2). (D) Hookworm (top right) attached to intestinal mucosa, Day 14; a previous attachment site can be seen in the background. (E and
F (see Vid















r)  Multiple adult hookworms causing hemorrhage as they feed, Day 16 
esidual lesions, Day 19 (3 days post-treatment). (I) Normal-looking bowe
ndoscopy images and panels C, D, H, and I are conventional endoscopy i
ntil four weeks after infection (Bowman et al., 1991). After
he treatment with Advantage Multi® of dogs with experi-
entally induced Ancylostoma ceylanicum infections, daily
ggs counts were negative for all treated dogs four days
fter treatment (Taweethavonsawat et al., 2010). The
apid clearing of the eggs in these dogs would suggest
hat, as was seen in the present study, there was likely
emoval of the worms as a source of eggs within a day of
reatment.
The endoscopic camera capsules have the capacity to
mage the entire small intestinal tract, and it would be
f interest to know when other helminths – and per-
aps most interestingly, tapeworms – are actually killed
y treatment. It would also be of interest to see the
esponse of larger helminths to treatment; this was noteo 3). (G) Healing laceration, Day 17 (1 day post-treatment). (H) Minor
9 (3 days post-treatment) (see Video 4). Panels A, B, and E–G are capsule
examined in this case. A. caninum grows rapidly, but the
worms were still quite small at the time this study was
performed. According to the careful work by Matsusaki
et al. (1965), the respective lengths in millimeters of male
and female A. caninum at different days post-infection
are 3.0–4.1, 3.3–3.8 (6 days); 5.0–6.5, 5.0–7.6 (10 days);
7.5–10.0, 8.0–11.5 (14 days); 8.1–10.1, 11.0–14.0 (18 days);
10.9–11.6, 13.5–14.8 (25 days); 10.2–12.2, 14.1–19.1 (35
days); and 11.0–12.9, 18.4–19.4 (45 days). Thus, most
of the worms seen in this study were less than half
(3.3–14.0 mm)  of what their lengths would have been
(10.9–14.8 mm)  at the typical time of necropsy 28–30 days
after infection, and still much smaller than they would have
been (11.0–19.4 mm)  when fully mature at one-and-a half
months of age.
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